Joined Nov 11, 2007
31,929 Blog Posts

Flash: Vertex Pharm beats by $0.18, beats on revs

Reports Q1 (Mar) loss of $0.91 per share, $0.18 better than the Thomson Reuters consensus of ($1.09); revenues were $73.7 mln which includes a $50 mln Japanese milestone payment and may not be comparable to the $25.1 mln consensus.

If you enjoy the content at iBankCoin, please follow us on Twitter